Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study

Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes

(2014) Elaine Hui et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Plasma DPP4 Activity Is Predictive of Prediabetes and Type 2 Diabetes Onset in Chinese Over a Four-Year Period: Result From the China National Diabetes and Metabolic Disorders Study

(2014) Tianpeng Zheng et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased plasma DPP4 activity predicts new-onset hypertension in Chinese over a 4-year period: possible associations with inflammation and oxidative stress

(2014) T Zheng et al.   JOURNAL OF HUMAN HYPERTENSION

Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study

(2014) T. Zheng et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

(2013) Paul E. Stevens   ANNALS OF INTERNAL MEDICINE

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor

(2013) Yuji Ishibashi et al.   Cardiovascular Diabetology

CD26/dipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation

(2013) Simone Leicht et al.   CLINICAL BIOCHEMISTRY

Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro

(2013) H. Sell et al.   DIABETES CARE

The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential

(2013) Hiroki Fujita et al.   KIDNEY INTERNATIONAL

Mechanisms of Diabetic Complications

(2013) Josephine M. Forbes et al.   PHYSIOLOGICAL REVIEWS

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

(2013) Martin Haluzík et al.   International Journal of Endocrinology

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people

(2012) Yasushi Kirino et al.   ENDOCRINE JOURNAL

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function

(2010) Gavin I. Welsh et al.   Cell Metabolism

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

(2010) M. E. Molitch et al.   DIABETES CARE

Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes

(2010) Nilani Jeyaratnaganthan et al.   GROWTH HORMONE & IGF RESEARCH

Prevalence of Diabetes among Men and Women in China

(2010) Wenying Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme

(2009) E. Matteucci et al.   CURRENT MEDICINAL CHEMISTRY